Probiotics for the Mitigation of Restistant Foodborne Pathogens

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Food Microbiology".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 3324

Special Issue Editors


E-Mail Website
Guest Editor
Department of Veterinary Science, University of Kentucky, Lexington, KY 40504, USA
Interests: zoonotic pathogens; drug discovery; antimicrobial resistance; gene expression during infection; control of foodborne bacterial pathogens; host responses (immunity) to infectious diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt
Interests: Zoonotic pathogens; antimicrobial resistant-foodborne pathogens; molecular epidemiology; whole-genome sequencing; comparative genomics; mobile genetic elements; metagenomics

Special Issue Information

Dear Colleagues,

Antimicrobial resistance has become a challenging problem affecting both humans and animals worldwide. The indiscriminate wide spread of antibiotics has led to the emergence of antimicrobial-resistant bacteria, leaving few therapeutic options for the treatment of multidrug-resistant bacteria. For the development of effective antimicrobial resistance (AMR) control measures and health policy choices, monitoring the spread of AMR infections is essential. Additionally, there is a critical need to control antibiotic alternatives such as probiotics.

This Special Issue welcomes high-quality original research papers on topics related to foodborne pathogens and probiotics. It will focus on topics including the presence and meaning of spoilage, useful and pathogenic microorganisms, technological strategies to promote their detection (traditional and molecular methods, biosensors) and control to improve food safety, reduction/elimination and use in food production. Apart from foodborne bacteria, scholars have also implemented many AMR testing to determine trends in AMR development. This Special Issue will welcome advanced studies on microorganism interactions in food matrices, starter cultures, bacteriocins, probiotics, antimicrobial resistance of foodborne pathogens and biotechnological aspects, risk assessment, molecular epidemiology, whole genome sequencing and microbial responses to stresses in the food chain and innovation in food protection, such as the use of bioprotective and antioxidant cultures.

Dr. Yosra A. Helmy
Dr. Hazem Ramadan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • food-borne pathogens
  • probiotics
  • prebiotics
  • gut microbiota
  • antimicrobial resistance

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

28 pages, 1494 KiB  
Review
Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives
by Mohamed E. Abouelela and Yosra A. Helmy
Microorganisms 2024, 12(3), 430; https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms12030430 - 20 Feb 2024
Viewed by 2372
Abstract
Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic [...] Read more.
Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic promise in addressing various chronic ailments. Offering multiple advantages over conventional probiotics, NGPs present opportunities for personalized probiotic therapies, involvement in synthetic biology and gene editing, participation in combination therapies, targeted delivery methods, and application in therapeutic settings. Our review discusses the potential therapeutic effect of the NGPs, covering diverse research trajectories for NGPs, including their identification, characterization, and targeted delivery. Furthermore, this review elucidates the influence of NGPs on critical aspects of human health, specifically, gut health, immune function, and broader health outcomes. Mechanistic insights encompass the production of bioactive compounds, competitive interactions with pathogenic bacteria, the modulation of immune cell activity, and the reinforcement of the gut barrier. What is noteworthy is that the current review points out the prevalent NGP strains and their diverse sources, providing a highlight for the comprehensive framework for understanding their potential applications and their future benefits in the domain of advanced therapeutics. Full article
(This article belongs to the Special Issue Probiotics for the Mitigation of Restistant Foodborne Pathogens)
Show Figures

Figure 1

Back to TopTop